abstract |
(A) providing a test sample from an individual; And (b) determining the biomarker signature of the test sample by measuring expression in a test sample of one or more biomarkers selected from the group defined in Table 1, wherein the biomarker signature of the test sample A method for determining a cancer-related disease state, the method comprising: expressing in a test sample of one or more biomarkers selected from the group defined in Table 1 above, the one or more prostate cancer-related disease states in the subject . The present invention also provides arrays and kits for use in the method. |